RDY $40.45 0.81 (2.0%)

    RDY Profile

    RDY trades on the NYSE.

    MEMBERSHIP
    --
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $7 Billion

    Mid-Cap
    With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, pharmaceutical services and active ingredients, and proprietary products and other, which make up most of the company's revenue at about 80%, 15%, and 3%, respectively. Most of the company's sales are based in the United States.

    RDY Earnings

    EPS

    65.93

    P/E

    26.17

    Q2 Earnings for Apr, May & Jun

    Mon, Jul 29, 2019

    Since Earnings Report

    RDY +3.7%

    Q3 Earnings for Jul, Aug & Sep

    Fri, Nov 1, 2019

    Since Earnings Report

    RDY +3.3%

    RDY Dividend

    Dividend Yield

    0.77%

    Dividend Rate

    $0.29

    Ex-Dividend Date

    Fri, Jul 13, 2018

    Dividend Pay Date

    Thu, Aug 9, 2018

    Dividend Frequency

    Annually

    Dividend Payments

    20 Payments

    RDY Charts

    52WL $34.67
    52WH $42.82
    All-Time $68.00


    RDY Industry Competitors


    DRUG MANUFACTURERS
    Novartis AG
    Astrazeneca
    GlaxoSmithKline
    Bausch Health Companies Inc. Common Stock
    Elanco Animal Health
    Catalent Inc
    Canopy Growth Corporation Common Stock
    The Medicines Co
    Horizon Pharma PLC
    Taro Pharmaceutical Industries Ltd



    Symbol MC DY Price Day YTD
    RDY $6.71 0.77% $40.45 -2.0% 7.7%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy